This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
4-7 December 2023
Convention Centre DublinDublin, Ireland

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest analytical techniques & vector technologies to revolutionise your cell, gene & gene edited ex vivo cell therapy programs

Thank you for attending CGT Europe 2022!

Thank you for attending the Cell & Gene Therapy Manufacturing & Commercialization Europe Hybrid Event! Please note that ConnectMe access has closed for all attendees and video access has been made available for 1 year on Streamly for All Access Pass Delegates. Please log into Streamly using the email you registered to our event with.

Having trouble logging in? Please contact Event Platform Manager Alice Flook at alice.flook@informa.com.

Join us at Next Generation CAR & T Cell Therapies (part of BPI West) on February 27 - March 2, 2023 at San Diego Convention Center San Diego, CA.

BRINGING YOU CUTTING EDGE CASE STUDIES TO IMPROVE EFFICIENCIES IN CELL & GENE THERAPY PRODUCTION

Cell Therapy (Recorded)

  • Discover process optimisation and implementation strategies for automated, closed and integrated systems in cell therapy manufacturing
  • Build your analytical toolbox to improve testing, characterisation & validation strategies
  • Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains

Gene Edited Ex Vivo Cell Therapy (Recorded)

  • Build a strategy for the scale up and manufacturing of for next generation “off the shelf” allogeneic and gene edited modalities
  • Get to grips with manufacturing and commercialisation strategies for CAR-Ts, NK cells, TCRs, TILs and iPSCs products
  • Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies

In Vivo Gene Therapy (Live-Streamed and Recorded)

  • Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
  • Discuss next generation non-viral gene editing techniques and their potential to transform the field
  • Develop analytical toolkits for AAV characterisation, validation and understanding CQAs

Elevate your conference experience by attending our pre-conference workshop: All Access Conference & Potency Assay Masterclass Workshop

What is this session about?

  • Overview of what potency is, and what it is not
  • Metrological principles and their application to bioassays
  • Considerations when qualifying and validating bioassays
  • Examples of potency assays for approved products (these will consume at least half of the time);
    • Examples of a cell and gene therapy potency assays
    • From initial ideas, through characterisation to the final potency method
    • Clinical correlation
    • Regulator objections and why.

Note: this workshop is aimed at those directly involved in developing potency assays. The case studies of real potency assays will delve deeply into the underlying science for each product discussed in order to understand why the approach was taken.

CONNECT WITH KEY BUYERS AT CELL & GENE THERAPY EUROPE 2023

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)20 7017 7247